GlassScriptPhysician profile
Andrew Ines
NPI 1174083729
$1,846.82
in general payments reported to CMS, 2019-2025
15 companies · $1,171 in 2025
The $1,171 reported for 2025 was more than what 81% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $125 · 2024: $551 · 2025: $1,171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,847.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,846.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $386.70 | 2023-2025 | |
| Bausch & Lomb Americas INC. | $340.50 | 2024-2025 | Vyzulta, Stellaris, Envista Envy Iol |
| Alcon Vision LLC | $257.84 | 2025 | Hydrus Microstent, Rocklatan |
| Regeneron Healthcare Solutions, INC. | $257.63 | 2024-2025 | Eylea Hd, Eylea |
| Rxsight INC | $168.13 | 2024-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Johnson & Johnson Surgical Vision, INC. | $146.54 | 2025 | Tecnis Iol, Tecnis Simplicity |
| Astellas Pharma US INC | $128.00 | 2025 | Izervay |
| Tarsus Pharmaceuticals, INC. | $37.64 | 2025 | Xdemvy |
| Oyster Point Pharma, INC. | $25.88 | 2025 | Tyrvaya |
| Biotissue Holdings INC. | $19.12 | 2025 | |
| Sun Pharmaceutical Industries INC. | $18.19 | 2024 | |
| Thea Pharma INC. | $17.12 | 2025 | Iyuzeh |
| Ani Pharmaceuticals, INC. | $17.00 | 2024 | Purified Cortrophin Gel |
| Amgen INC. | $15.28 | 2025 | Tepezza |
| New World Medical,INC. | $11.25 | 2025 | Streamline, Via360, Kahook Dual Blade |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Ines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.